Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apex Healthcare Bhd's yield on cost for the quarter that ended in Sep. 2025 was 7.90.
The historical rank and industry rank for Apex Healthcare Bhd's 5-Year Yield-on-Cost % or its related term are showing as below:
XKLS:7090'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.26 Med: 6.15 Max: 14.53
Current: 7.9
During the past 13 years, Apex Healthcare Bhd's highest Yield on Cost was 14.53. The lowest was 3.26. And the median was 6.15.
XKLS:7090's 5-Year Yield-on-Cost % is not ranked
in the Medical Distribution industry.
Industry Median: 3.09
vs XKLS:7090: 7.90
Apex Healthcare Bhd (XKLS:7090) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Apex Healthcare Bhd 5-Year Yield-on-Cost % Related Terms
XKLS:7090 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's 5-Year Yield-on-Cost % falls into.
Apex Healthcare Bhd 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Apex Healthcare Bhd (XKLS:7090) has a 5-Year Yield-on-Cost % of 7.90 as of Jul. 26, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Apex Healthcare Bhd and its competitors. This is 28% above median its historical median of 6.15. Over the past decade, Apex Healthcare Bhd's 5-Year Yield-on-Cost % has ranged from 3.26 to 14.53.
Is Apex Healthcare Bhd's 5-Year Yield-on-Cost % too high?
Apex Healthcare Bhd's current 5-Year Yield-on-Cost % of 7.90 is 28% above median its 10-year median of 6.15. Over the past 10 years, this metric has ranged from a low of 3.26 to a high of 14.53. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.09. Apex Healthcare Bhd's value of 7.90 is 155.7% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's 5-Year Yield-on-Cost % compare to MCK and COR?
Apex Healthcare Bhd's 5-Year Yield-on-Cost % of 7.90 can be compared against companies in the Medical Distribution industry. The industry median 5-Year Yield-on-Cost % is 3.09. Apex Healthcare Bhd's value of 7.90 is 155.7% above this benchmark. Historically, Apex Healthcare Bhd's own 5-Year Yield-on-Cost % has ranged from 3.26 to 14.53 over the past decade. While the company's 10-year median is 6.15 vs. the industry median of 3.09, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.09, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current 5-Year Yield-on-Cost % of 7.90 is 155.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current 5-Year Yield-on-Cost % is 7.90, which is 28% above median its own 10-year median of 6.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current 5-Year Yield-on-Cost % of 7.90. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current 5-Year Yield-on-Cost % is 7.90, which is 28% above median its 10-year median of 6.15 and 155.7% above the Medical Distribution industry median of 3.09. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current 5-Year Yield-on-Cost % is 7.90 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
5-Year Yield-on-Cost %: 7.90 (28% above median its 10-year median of 6.15)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 155.7% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
